Display options
Cite
Turner N, Forcato M, Nuzzo S, et al. A multifactorial 'Consensus Signature' by . NPJ Breast Cancer. 2015;1:15003doi: 10.1038/npjbcancer.2015.3.
Turner, N., Forcato, M., Nuzzo, S., Malorni, L., Bicciato, S., & Di Leo, A. (2015). A multifactorial 'Consensus Signature' by . NPJ breast cancer, 115003. https://doi.org/10.1038/npjbcancer.2015.3
Turner, Natalie, et al. "A multifactorial 'Consensus Signature' by ." NPJ breast cancer vol. 1 (2015): 15003. doi: https://doi.org/10.1038/npjbcancer.2015.3
Turner N, Forcato M, Nuzzo S, Malorni L, Bicciato S, Di Leo A. A multifactorial 'Consensus Signature' by . NPJ Breast Cancer. 2015 Jun 02;1:15003. doi: 10.1038/npjbcancer.2015.3. eCollection 2015. PMID: 28721363; PMCID: PMC5515202.
Copy Download .nbib Format: NLM
Share it on

NPJ Breast Cancer. 2015 Jun 02;1:15003. doi: 10.1038/npjbcancer.2015.3. eCollection 2015.

A multifactorial 'Consensus Signature' by .

NPJ breast cancer

Natalie Turner, Mattia Forcato, Simona Nuzzo, Luca Malorni, Silvio Bicciato, Angelo Di Leo

Affiliations

  1. 'Sandro Pitigliani Medical Oncology Department, Prato Hospital, Istituto Toscano Tumori, Prato, Italy.
  2. Department of Biomedical Sciences, Centre for Genome Research, University of Modena and Reggio Emilia, Modena, Italy.
  3. Translational Research Unit, Prato Hospital, Istituto Toscano Tumori, Prato, Italy.

PMID: 28721363 PMCID: PMC5515202 DOI: 10.1038/npjbcancer.2015.3

Abstract

RESULTS: In the training set, 29 of 147 patients had pCR after anthracycline-based chemotherapy. Various combinations of components were evaluated, with the most powerful anthracycline response predictors being

CONCLUSIONS: With further validation,

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Lancet. 2012 Feb 4;379(9814):432-44 - PubMed
  2. N Engl J Med. 2011 Oct 6;365(14):1273-83 - PubMed
  3. J Clin Oncol. 2008 Nov 1;26(31):5027-35 - PubMed
  4. J Clin Oncol. 2011 Apr 20;29(12):1578-86 - PubMed
  5. Breast Cancer Res. 2008;10(4):R65 - PubMed
  6. Breast Cancer Res Treat. 2010 Aug;123(1):171-5 - PubMed
  7. Clin Cancer Res. 2010 Nov 1;16(21):5351-61 - PubMed
  8. N Engl J Med. 2006 Aug 10;355(6):560-9 - PubMed
  9. Breast Cancer Res Treat. 2011 Jul;128(1):127-36 - PubMed
  10. JAMA. 2011 May 11;305(18):1873-81 - PubMed
  11. J Natl Cancer Inst. 2011 Feb 2;103(3):264-72 - PubMed
  12. Nat Med. 2009 Jan;15(1):68-74 - PubMed
  13. Lancet Oncol. 2011 Nov;12(12):1134-42 - PubMed
  14. Biostatistics. 2007 Jan;8(1):118-27 - PubMed
  15. Breast Cancer Res Treat. 2013 Jan;137(1):213-23 - PubMed
  16. Clin Cancer Res. 2003 Jan;9(1 Pt 2):447S-54S - PubMed
  17. Nat Med. 2010 Feb;16(2):214-8 - PubMed
  18. Breast Cancer Res. 2006;8(6):215 - PubMed
  19. Cell. 2009 Apr 3;137(1):87-98 - PubMed
  20. Breast Cancer Res Treat. 2007 Dec;106(2):181-9 - PubMed
  21. Nature. 2012 Jul 19;487(7407):380-4 - PubMed
  22. J Clin Oncol. 2011 Mar 1;29(7):859-67 - PubMed
  23. Clin Cancer Res. 2008 Aug 15;14(16):5158-65 - PubMed
  24. Clin Cancer Res. 2002 May;8(5):1107-16 - PubMed

Publication Types